Advancing the Frontier: Neuroimaging Techniques in the Early Detection and Management of Neurodegenerative Diseases
Ahmed S Akram,
No information about this author
Han Grezenko,
No information about this author
Prem Singh
No information about this author
et al.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 29, 2024
Alzheimer's
and
Parkinson's
diseases
are
among
the
most
prevalent
neurodegenerative
conditions
affecting
aging
populations
globally,
presenting
significant
challenges
in
early
diagnosis
management.
This
narrative
review
explores
pivotal
role
of
advanced
neuroimaging
techniques
detecting
managing
these
at
stages,
potentially
slowing
their
progression
through
timely
interventions.
Recent
advancements
MRI,
such
as
ultra-high-field
systems
functional
have
enhanced
sensitivity
for
subtle
structural
changes.
Additionally,
development
novel
amyloid-beta
tracers
other
emerging
modalities
like
optical
imaging
transcranial
ultrasonography
improved
diagnostic
accuracy
capability
existing
methods.
highlights
clinical
applications
technologies
diseases,
where
they
shown
performance,
enabling
earlier
intervention
better
prognostic
outcomes.
Moreover,
integration
artificial
intelligence
(AI)
longitudinal
research
is
a
promising
enhancement
to
refine
detection
strategies
further.
However,
this
also
addresses
technical,
ethical,
accessibility
field,
advocating
more
extensive
use
overcome
barriers.
Finally,
we
emphasize
need
holistic
approach
that
incorporates
both
neurological
psychiatric
perspectives,
which
crucial
optimizing
patient
care
outcomes
management
diseases.
Language: Английский
Biomechanical Risk Classification in Repetitive Lifting Using Multi-Sensor Electromyography Data, Revised National Institute for Occupational Safety and Health Lifting Equation, and Deep Learning
Fatemeh Davoudi Kakhki,
No information about this author
Hardik Vora,
No information about this author
Armin Moghadam
No information about this author
et al.
Biosensors,
Journal Year:
2025,
Volume and Issue:
15(2), P. 84 - 84
Published: Feb. 1, 2025
Repetitive
lifting
tasks
in
occupational
settings
often
result
shoulder
injuries,
impacting
both
health
and
productivity.
Accurately
assessing
the
biomechanical
risk
of
these
remains
a
significant
challenge
ergonomics,
particularly
within
manufacturing
environments.
Traditional
assessment
methods
frequently
rely
on
subjective
reports
limited
observations,
which
can
introduce
bias
yield
incomplete
evaluations.
This
study
addresses
limitations
by
generating
utilizing
comprehensive
dataset
containing
detailed
time-series
electromyography
(EMG)
data
from
25
participants.
Using
high-precision
wearable
sensors,
EMG
were
collected
eight
muscles
as
participants
performed
repetitive
tasks.
For
each
task,
index
was
calculated
using
revised
National
Institute
for
Occupational
Safety
Health
(NIOSH)
equation
(RNLE).
Participants
completed
cycles
low-risk
high-risk
four-minute
period,
allowing
muscle
performance
under
realistic
working
conditions.
extensive
dataset,
comprising
over
7
million
points
sampled
at
approximately
1259
Hz,
leveraged
to
develop
deep
learning
models
classify
risk.
To
provide
actionable
insights
practical
ergonomics
assessments,
statistical
features
extracted
raw
data.
Three
models,
Convolutional
Neural
Networks
(CNNs),
Multilayer
Perceptron
(MLP),
Long
Short-Term
Memory
(LSTM),
employed
analyze
predict
level.
The
CNN
model
achieved
highest
performance,
with
precision
98.92%
recall
98.57%,
proving
its
effectiveness
real-time
assessments.
These
findings
underscore
importance
aligning
architectures
characteristics
optimize
management.
By
integrating
sensors
this
enables
precise,
real-time,
dynamic
significantly
enhancing
workplace
safety
protocols.
approach
has
potential
improve
planning
reduce
incidence
severity
work-related
musculoskeletal
disorders,
ultimately
promoting
better
outcomes
across
various
settings.
Language: Английский
AI-Optimized Electrochemical Aptasensors for Stable, Reproducible Detection of Neurodegenerative Diseases, Cancer, and Coronavirus
Amira Elsir Tayfour Ahmed,
No information about this author
Th. S. Dhahi,
No information about this author
Tahani A Attia
No information about this author
et al.
Heliyon,
Journal Year:
2024,
Volume and Issue:
11(1), P. e41338 - e41338
Published: Dec. 18, 2024
AI-optimized
electrochemical
aptasensors
are
transforming
diagnostic
testing
by
offering
high
sensitivity,
selectivity,
and
rapid
response
times.
Leveraging
data-driven
AI
techniques,
these
sensors
provide
a
non-invasive,
cost-effective
alternative
to
traditional
methods,
with
applications
in
detecting
molecular
biomarkers
for
neurodegenerative
diseases,
cancer,
coronavirus.
The
performance
metrics
outlined
the
comparative
table
illustrate
significant
advancements
enabled
integration.
Sensitivity
increases
from
60
75
%
ordinary
85-95
%,
while
specificity
improves
70-80
90-98
%.
This
enhanced
allows
ultra-low
detection
limits,
such
as
10
fM
carcinoembryonic
antigen
(CEA)
20
mucin-1
(MUC1)
using
Electrochemical
Impedance
Spectroscopy
(EIS),
1
pM
prostate-specific
(PSA)
Differential
Pulse
Voltammetry
(DPV).
Similarly,
Square
Wave
(SWV)
potentiometric
have
detected
alpha-fetoprotein
(AFP)
at
5
epithelial
cell
adhesion
molecule
(EpCAM)
100
fM,
respectively.
integration
also
enhances
reproducibility,
reduces
false
positives
negatives
(from
15-20
5-10
%),
significantly
decreases
times
10-15
s
2-3
s).
These
improve
data
processing
speeds
min
per
sample
2-5
min)
calibration
accuracy
(<2
margin
of
error
compared
expanding
application
scope
multi-target
biomarker
detection.
review
highlights
how
position
powerful
tools
personalized
treatment,
point-of-care
testing,
continuous
health
monitoring.
Despite
higher
cost
($500-$1,500/unit),
their
portability
promise
revolutionize
healthcare,
environmental
monitoring,
food
safety,
ultimately
improving
public
outcomes.
Language: Английский
Key Aspects of Biosensing for Instant Screening Tests
Biosensors and Bioelectronics X,
Journal Year:
2024,
Volume and Issue:
20, P. 100529 - 100529
Published: Aug. 13, 2024
Language: Английский
Wearable Optical Sensors: Toward Machine Learning-Enabled Biomarker Monitoring
Shadab Faham,
No information about this author
Sina Faham,
No information about this author
Bakhtyar Sepehri
No information about this author
et al.
Chemistry Africa,
Journal Year:
2024,
Volume and Issue:
7(8), P. 4175 - 4192
Published: Aug. 16, 2024
Language: Английский
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations
Diagnostics,
Journal Year:
2024,
Volume and Issue:
14(18), P. 2037 - 2037
Published: Sept. 13, 2024
Laboratory
medicine
has
undergone
a
deep
and
multifaceted
revolution
in
the
course
of
human
history,
both
organizational
technical
terms.
Over
past
century,
there
been
growing
recognition
need
to
centralize
numerous
diagnostic
activities,
often
similar
or
identical
but
located
different
clinical
departments,
into
common
environment
(i.e.,
medical
laboratory
service),
followed
by
progressive
centralization
tests
from
smaller
laboratories
larger
facilities.
Nevertheless,
technological
advances
that
emerged
at
beginning
new
millennium
have
helped
create
testing
culture
characterized
countervailing
trend
decentralization
some
closer
patients
caregivers.
The
forces
driven
this
(centripetal)
counter-revolution
essentially
include
few
key
concepts,
namely
“home
testing”,
“portable
even
wearable
devices”
“remote
patient
monitoring”.
By
their
very
nature,
services
remote
testing/monitoring
are
not
contradictory,
may
well
coexist,
with
choice
one
other
depending
on
demographic
characteristics
patient,
type
analytical
procedure
logistics
local
organization
care
system.
Therefore,
article
aims
provide
general
overview
self-testing,
particular
focus
portable
(including
implantable)
devices.
Language: Английский
Monitoring Substance Use with Fitbit Biosignals: A Case Study on Training Deep Learning Models Using Ecological Momentary Assessments and Passive Sensing
Shizhe Li,
No information about this author
Changfeng Fan,
No information about this author
Ali Kargarandehkordi
No information about this author
et al.
AI,
Journal Year:
2024,
Volume and Issue:
5(4), P. 2725 - 2738
Published: Dec. 3, 2024
Substance
use
disorders
affect
17.3%
of
Americans.
Digital
health
solutions
that
machine
learning
to
detect
substance
from
wearable
biosignal
data
can
eventually
pave
the
way
for
real-time
digital
interventions.
However,
difficulties
in
addressing
severe
between-subject
heterogeneity
have
hampered
adaptation
approaches
detection,
necessitating
more
robust
technological
solutions.
We
tested
utility
personalized
using
participant-specific
convolutional
neural
networks
(CNNs)
enhanced
with
self-supervised
(SSL)
drug
use.
In
a
pilot
feasibility
study,
we
collected
9
participants
Fitbit
Charge
5
devices,
supplemented
by
ecological
momentary
assessments
collect
labels
implemented
baseline
1D-CNN
model
traditional
supervised
and
an
experimental
SSL-enhanced
improve
individualized
feature
extraction
under
limited
label
conditions.
Results:
Among
participants,
achieved
average
area
receiver
operating
characteristic
curve
score
across
0.695
CNNs
0.729
SSL
models.
Strategic
selection
optimal
threshold
enabled
us
optimize
either
sensitivity
or
specificity
while
maintaining
reasonable
performance
other
metric.
Conclusion:
These
findings
suggest
potential
enhance
monitoring
systems.
small
sample
size
this
study
limits
its
generalizability
diverse
populations,
so
call
future
research
explores
SSL-powered
personalization
at
larger
scale.
Language: Английский